Showing posts with label Ophthalmology journal impact factor. Show all posts
Showing posts with label Ophthalmology journal impact factor. Show all posts

Thursday, 1 November 2018

A Metastatic Tumor of Ewing’s Sarcoma in the Orbit (TOOAJ)- Lupine Publishers




A 16-year-old male patient was admitted to our clinic in June 2017 with a complaint of swelling in the right eye for 2 days. In the examination, the best corrected vision acuity (BCVA) was 0,8 for the right eye and 0,9 for the left eye by Snellen. Right periobital edema, proptosis and ptosis were present, and the eye movements were restricted in all directions. There was a chemosis in the right eye in the slit lamp examination and a slight deletion of the nasal borders of the bilateral optic disc in the fundus examination. When the story of the patient was questioned, we learned that he was treated with a diagnosis of Ewing’s sarcoma in the left fibula 1 year ago and was diagnosed as urgent because of a metastatic tumor causes the medulla spinalis compression which was found in the lumbar region 1 week before. The massive lesion on the posterior wall of the right orbit was detected in the orbital tomography, which made us think metastasis of the Ewing’s sarcoma primarily for the differential diagnosis and the patient was directed to the Department of Pediatric Oncology. Upon observation of multiple bone involvement in the Positron Emission Tomography, the patient was initiated a 5-day Iphosphamide + Carboplastin + Etoposide systemic chemotherapy protocol. On day 2, a dramatic regression was observed in the patient’s symptoms. At 1-week follow-up, the BCVA was bilateral 1.0, the eye movements were normal in all directions, the slit-lamp and fundus findings and the intraocular pressure were normal .


Tuesday, 9 October 2018

Treatment Of Idiopathic Choroidal Neovascular Membrane in Young Female Patient by Intravitreal Aflibercept Injection (TOOAJ)- Lupine Publishers



This case is about idiopathic choroidal neovascular membrane (CNV) in a 30 year old female patient who presented with visual loss in the right eye for one month. The initial vision acuity (VA) of the patient was 1/10. In the fundus fluorescein angiography (FFA) and optical coherence tomography (OCT) of the patient, staining and macular leakage consistent with CNV in the peripapillary region were detected. Intravitreal injection of aflibercept was performed on the patient’s eye. At the first month follow-up, the patient’s VA was 10/10.


Wednesday, 3 October 2018

Detection of The Muscle Affected In Vertical Deviation Induced by A Single Muscle (TOOAJ)-Lupine Publishers



To detect the muscle affected in vertical deviation induced by a single muscle. A table was formed combining the Parks-Bielschowsky and Bajandas tests. Detection of the muscle affected in vertical deviation induced by a single muscle is made possible by means of the table formed in accordance with the principles of the Parks-Bielschowsky and Bajandas tests.If a single muscle is responsible for the deviation, it can be determined using these two tests. However, application of these tests may, on occasions though, cause some confusion. Through the table, it is quite easy for physicians to detect the affected muscle using the directions mentioned.


Wednesday, 26 September 2018

Atypical Presentation of Ocular Toxoplasmosis with Exudative Retinal Detachment (TOOAJ)-Lupine Publishers



Subretinal fluid, a common clinical pathological entity, is seen in a variety of ocular disorders. Though inflammation is associated with the development of subretinal fluid, toxoplasmosis is an unusual causative agent. A 54 year old lady presented with atypical ocular findings of exudative retinal detachment due to toxoplasmosis. The diagnosis was misinterpreted first as sarcoidosis based on HRCT chest picture, later on diagnosed as ocular toxoplasmosis on correlating clinical presentation, fundus fluorescein angiography (FFA), optical coherence tomography (OCT) findings and serology. Patient was managed with a combination of oral anti Toxoplasma drugs, and oral corticosteroids.





Wednesday, 19 September 2018

Role of Communities to Prevent Corneal Blindness (TOOAJ)-Lupine Publishers




The community needs to take appropriate actions itself, as well as actions by government and non-governmental organizations. Prevention of corneal blindness can take place at three stages:a) Level-1 Prevention: Actions taken to prevent the onset of disease. Level-2 Prevention: Actions taken to prevent complications and the development of visual disability due to an existing disease. Level-3 Prevention: After the immediate resolution of the problem by surgery or other treatment, actions should be taken to reduce existing disability from disease complications right up to the point when some patient either seen by an eye care worker or admitted to hospital, the community should influence and trace out the ground reality or the actual reasons .An eye care worker must have little control over the following:The risk factors and immediate medical causes and the contributing and social factors. The community has the capacity to influence these factors, either through change in the behavior of individuals, or by bringing improvements at the community level. The eye care worker's role is very vital when they participating in programmes to reduce corneal blindness. Progressive and active campaign of community awareness will ultimately result to build up a role of active partner in the prevention of corneal blindness.


Friday, 7 September 2018

Implication of Intrinsic Intraocular Risk Factors at Ocular Blood Flow to Primary Glaucoma (TOOAJ)- Lupine Publishers


Purpose: To assess the implication of intrinsic intraocular risk factors at ocular blood flow (OBF) to primary glaucoma (POAG).
Method: In a retrospective control study included 51 consecutive patients, mean age 50, 5±7, in follow-up 2008-2012 divided in control group (CG) 15 patients without POAG, group A (GRA) 15 patients with POAG, group B (GRB) 21 patients with POAG, 9 of them with disc hemorrhage (DH) and 12 with peripapillary atrophy (PPA). We performed baseline glaucoma examination including monitoring pulsatile ocular blood flow (POBFA), pulse amplitude (PA), central corneal thickness (CCT), OCT and visual field (VF) examination. Exclusion criteria: Previous ocular trauma and surgery, pathologies with evident VD. Paired T-test and linear regressions used for statistical analysis.
Results: Our findings indicated a strong correlation between OBFA, IOP and an interrelation between POAG and intrinsic risk factors, DH and PPA (P=0,001). In GRB versus CG,GRA POBF were very sensible and fluctuated depending on the intraocular VD.CCT and IOP changes (P=0,002), showed the abnormality auto regulation(r=0,650). In GRB the POBF and PA were lower ≥8% than other subgroups (P<0,001). LATANOPROST with IOP reduction from baseline 30, 8%, POBF improved 16,6%, PA 10% was the best therapy in GRA. In GRB the switch therapy DORZOLAMIDE + LATANOPROST, DORZOLAMIDE + BIMATOPROST IOP reduction 33.0% from baseline, POBF improved 36%, PA 22%, with added therapy NILVADIPIN 60 mgr + GINKGO BILOBA 150 mg, VISIONACE plus the hemodynamic parameters further improved ≥5%.